Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients

Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients

Cytokine storm resulting from SARS-CoV-2 infection is one of the leading causes of acute respiratory distress syndrome (ARDS) and lung fibrosis. We investigated the effect of inflammatory molecules to identify any marker that is related to lung fibrosis in coronavirus disease 2019 (COVID-19). Sevent...

Full description

Bibliographic Details
Main Authors: Zhong-Jie Hu, Jia Xu, Ji-Ming Yin, Li Li, Wei Hou, Li-Li Zhang, Zhen Zhou, Yi-Zhou Yu, Hong-Jun Li, Ying-Mei Feng, Rong-Hua Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Immunology
Subjects:
SRAS-CoV-2
inflammation
pulmonary fibrosis
COVID-19
IFN-γ
artificial intelligence 2
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.585647/full

Similar Items

Similar Items